Metacrine, Inc.
MTCR · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $1,450 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $1,450 |
| % Margin | – | – | – | 100% |
| R&D Expenses | $45,474 | $26,790 | $25,973 | $22,937 |
| G&A Expenses | $15,605 | $9,900 | $4,031 | $5,242 |
| SG&A Expenses | $15,605 | $9,900 | $4,031 | $5,242 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $61,079 | $36,690 | $30,004 | $28,179 |
| Operating Income | -$61,079 | -$36,690 | -$30,004 | -$26,729 |
| % Margin | – | – | – | -1,843.4% |
| Other Income/Exp. Net | -$1,128 | -$614 | $1,071 | $908 |
| Pre-Tax Income | -$62,207 | -$37,304 | -$28,933 | -$25,821 |
| Tax Expense | -$972 | -$931 | $347 | $0 |
| Net Income | -$61,235 | -$36,373 | -$29,280 | -$25,821 |
| % Margin | – | – | – | -1,780.8% |
| EPS | -1.45 | -3.87 | -1.52 | -1.35 |
| % Growth | 62.5% | -154.6% | -12.6% | – |
| EPS Diluted | -1.45 | -3.87 | -1.52 | -1.35 |
| Weighted Avg Shares Out | 42,108 | 9,404 | 19,222 | 19,062 |
| Weighted Avg Shares Out Dil | 42,108 | 9,404 | 19,222 | 19,062 |
| Supplemental Information | – | – | – | – |
| Interest Income | $102 | $494 | $1,418 | $934 |
| Interest Expense | $1,202 | $1,012 | $347 | $0 |
| Depreciation & Amortization | $972 | $931 | $2,248 | $829 |
| EBITDA | -$60,033 | -$35,361 | -$27,756 | -$24,992 |
| % Margin | – | – | – | -1,723.6% |